How to Get Jatenzo in Hawaii: Telehealth, Prescriptions, and Pharmacies

What Is Jatenzo and Why Hawaii Patients Seek It

Jatenzo is the first FDA-approved oral testosterone formulation designed to bypass first-pass liver metabolism by absorbing through intestinal lymphatic channels rather than portal circulation. Twice-daily dosing with a meal of at least 10 grams of fat produces steady serum testosterone in the normal male range for most treated patients.

The FDA granted approval on March 27, 2019 for adult males with primary or secondary hypogonadism confirmed by clinical signs and two separate morning testosterone measurements below 300 ng/dL [1]. Because Jatenzo is an oral capsule rather than a gel, patch, or injection, Hawaii patients often request it specifically to avoid transfer risk to partners, eliminate injection-site management, and maintain discretion in shared living situations common across the island communities.

Swerdloff et al. reported in the Journal of Clinical Endocrinology and Metabolism (2020, N=166) that 87% of men receiving oral testosterone undecanoate achieved average testosterone concentrations (C-avg) within the normal range of 300 to 1000 ng/dL at the optimized dose [2]. Mean C-avg was 558 ng/dL at 365 days, and mean diastolic blood pressure increased by 2.0 mmHg, a finding that has driven the FDA to require blood pressure monitoring before and during therapy [2]. The FDA label carries a boxed warning stating that Jatenzo can cause blood pressure increases that increase the risk of major adverse cardiovascular events [1].

Male hypogonadism affects an estimated 2.1% to 3.8% of men aged 40 to 79 years, according to data reported in the Journal of Clinical Endocrinology and Metabolism [3]. In Hawaii, where the male population skews toward outdoor, physically active lifestyles, under-diagnosis remains common because fatigue and low libido are attributed to work schedules rather than endocrine deficiency.

Hawaii Telehealth Law and Jatenzo Prescribing

Hawaii permits telehealth prescribing of controlled substances under state law, provided the prescriber holds an active Hawaii DEA registration and the patient completes a real-time audio-visual encounter with a licensed provider. Testosterone is a Schedule III controlled substance under the Controlled Substances Act [4], so this requirement applies to every Jatenzo prescription.

Hawaii Revised Statutes Chapter 453 and the Hawaii Medical Board's telehealth rules allow licensed out-of-state practitioners to treat Hawaii patients only if they hold a Hawaii medical license or qualify under a recognized reciprocity or interstate compact arrangement. The Interstate Medical Licensure Compact (IMLC) currently includes Hawaii, which means physicians licensed in other IMLC member states may obtain an expedited Hawaii license and prescribe via telehealth [5].

Practically, patients should verify three things before booking an online TRT consultation: that the platform's prescribers hold active Hawaii licenses, that the platform can transmit electronic prescriptions to Hawaii-licensed pharmacies, and that the platform's prescription management software is compatible with Schedule III electronic prescribing requirements under Hawaii law.

The American Urological Association 2018 guideline on testosterone deficiency states that "clinicians should use a total testosterone level below 300 ng/dL as a reasonable cut-off in support of the diagnosis of low testosterone" [6]. A telehealth provider in Hawaii is required to document at least two low testosterone measurements before initiating therapy, consistent with both the AUA guideline and the Jatenzo FDA label [1][6].

Required Labs Before a Jatenzo Prescription in Hawaii

Most prescribers require a standard panel before writing a Jatenzo Rx. Labs should be drawn in the morning, ideally between 7 a.m. and 10 a.m., because testosterone follows a circadian rhythm with peak secretion in early morning [7].

The minimum panel includes:

• Total testosterone (two separate morning draws on different days)
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to classify primary vs. secondary hypogonadism
• Complete blood count (CBC) with hematocrit, because testosterone therapy raises erythropoiesis and hematocrit above 54% warrants dose reduction or cessation [1]
• Prostate-specific antigen (PSA) in men aged 40 and older, per the Endocrine Society Clinical Practice Guideline [8]
• Baseline blood pressure measurement, documented in the medical record, per the boxed warning requirement in the Jatenzo FDA label [1]
• Comprehensive metabolic panel (CMP) to evaluate hepatic and renal function

The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states: "We recommend measuring hematocrit at baseline, at 3 to 6 months, and then annually" [8]. Hawaii telehealth platforms typically route lab orders to Quest Diagnostics or LabCorp, both of which operate patient service centers on Oahu, Maui, and the Big Island. Neighbor island patients on Molokai or Lanai may need to arrange specimen collection through Molokai General Hospital or a visiting phlebotomy service.

Quest Diagnostics operates at least 14 patient service centers across Hawaii, with locations in Honolulu, Kailua, Pearl City, Kahului, and Hilo [9]. Results typically return within 24 to 72 hours for standard panels, meaning the full lab-to-prescription timeline can be as short as 3 to 5 business days after the initial consultation.

Prior Authorization Requirements for Jatenzo in Hawaii

Hawaii Medicaid does not cover Jatenzo for male hypogonadism. Commercial plans administered through Hawaii-based insurers, including HMSA (Hawaii Medical Service Association, the local Blue Cross Blue Shield affiliate) and Kaiser Permanente Hawaii, may require prior authorization (PA) before dispensing [10].

A typical PA submission for Jatenzo must include:

1. Two morning total testosterone values below 300 ng/dL with dates and laboratory names
2. Documentation of clinical symptoms (fatigue, reduced libido, decreased muscle mass, or sexual dysfunction)
3. Prescriber attestation that the patient has confirmed hypogonadism, not age-related decline alone
4. Evidence of an adequate trial of a lower-cost testosterone formulation (usually testosterone cypionate injection or a topical gel) if the plan uses step therapy

The Endocrine Society guideline notes that "testosterone therapy should be prescribed only to men who have symptoms and signs consistent with androgen deficiency and consistently low serum testosterone concentrations" [8]. Insurers cite this language when requiring symptom documentation as a PA condition.

If the commercial plan denies coverage, patients have two practical options: cash-pay at retail pharmacy or a 503A compounding pharmacy. The cash-pay retail price for Jatenzo 237 mg (60 capsules, one month supply) typically ranges from $550 to $750 before manufacturer savings programs. Tolmar offers a Jatenzo Savings Card that may reduce out-of-pocket cost to as low as $75 per month for eligible commercially insured patients [1]. Uninsured patients do not qualify for the savings card but may access patient assistance through Tolmar's patient support program.

503A Compounding Pharmacies and Oral Testosterone Undecanoate in Hawaii

Hawaii-licensed 503A compounding pharmacies may prepare oral testosterone undecanoate capsules for individual patients when a licensed prescriber writes a patient-specific prescription. The distinction from branded Jatenzo is important: 503A pharmacies compound to individual prescriptions and are not manufacturing commercial product [11].

The FDA's guidance on compounding and the Federal Food, Drug, and Cosmetic Act clarifies that 503A pharmacies may compound drugs that are commercially available only when there is a specific documented clinical reason the commercial product does not meet the patient's needs, such as an allergy to an excipient or a required strength not commercially available [11]. Because Jatenzo comes only in 237 mg capsules, a prescriber seeking a 158 mg or 316 mg dose would have a documented clinical basis for a compound.

Hawaii has 503A-licensed pharmacies on Oahu, and several nationally operating 503A pharmacies are licensed in Hawaii and ship via overnight courier to all Hawaiian islands. The PCAB (Pharmacy Compounding Accreditation Board) accreditation list can help patients and prescribers verify which pharmacies meet quality standards [12]. Shipping to Maui, Kauai, and the Big Island via overnight courier generally costs $25 to $45 and adds one business day to the fulfillment timeline.

How to Transfer a Jatenzo Prescription to Hawaii

Patients relocating to Hawaii from the continental United States with an existing Jatenzo prescription face two constraints. First, Schedule III prescriptions may be transferred between pharmacies only once under federal DEA rules, and only if neither state prohibits such transfers [4]. Second, the prescribing provider must hold an active Hawaii DEA registration or the prescription cannot be filled at a Hawaii-licensed pharmacy.

The practical path for most relocating patients is:

1. Obtain a 30-day supply refill in the departing state before the move.
2. Schedule a telehealth or in-person consultation with a Hawaii-licensed prescriber within 30 days of arrival.
3. Have the new Hawaii prescriber issue a fresh Schedule III prescription electronically to a Hawaii-licensed pharmacy.

An alternative used by some patients is to maintain care with a telehealth platform whose prescribers hold both the original state license and an active Hawaii license, in which case continuity of care is straightforward and no prescription transfer is needed.

Finding a Jatenzo Prescriber in Hawaii: In-Person vs. Telehealth

In-person specialists who commonly prescribe Jatenzo in Hawaii include endocrinologists, urologists, and men's health physicians. On Oahu, Hawaii Pacific Health and The Queen's Medical Center both house endocrinology and urology departments with practitioners experienced in testosterone deficiency management. Maui Health System in Wailuku and Hilo Medical Center on the Big Island provide similar services for neighbor island residents.

Telehealth platforms operating in Hawaii represent the faster access path for most patients. A typical telehealth workflow runs as follows: online intake form (10 minutes), asynchronous review by a licensed provider, lab order sent to a local draw site, follow-up audio-visual visit to review results and obtain prescription (20 to 30 minutes), and electronic prescription transmitted to a mail-order or local pharmacy. Total elapsed time from intake to prescription dispatch is typically 5 to 10 business days [13].

The American Telemedicine Association has published guidelines noting that synchronous audio-visual encounters meet the standard of care for initial evaluations of chronic hormone-deficiency conditions when physical examination findings are not required to make the diagnosis [13]. Hypogonadism diagnosed by laboratory criteria alone qualifies under this framework for most telehealth platforms.

NPs with full prescriptive authority and PAs practicing under supervising physician agreements may also prescribe Jatenzo in Hawaii. Hawaii is a full-practice-authority state for nurse practitioners, meaning NPs may prescribe Schedule III controlled substances independently without physician oversight, provided they hold an active DEA registration [14]. PA prescribing of Schedule III substances in Hawaii requires a formal delegation agreement with a supervising physician who also holds Hawaii DEA registration [14].

Jatenzo Dosing, Administration, and Monitoring for Hawaii Patients

Jatenzo is initiated at 237 mg twice daily with food. The FDA label instructs prescribers to check a serum testosterone level 3 to 5 hours after the morning dose at approximately 28 days into therapy [1]. If testosterone falls below 300 ng/dL, the dose may be increased to 316 mg twice daily. If testosterone exceeds 1050 ng/dL, the dose should be reduced to 158 mg twice daily [1].

Blood pressure must be re-assessed at approximately 28 days and monitored regularly throughout therapy. In Swerdloff et al. (N=166), mean systolic blood pressure increased by 3.5 mmHg from baseline to day 90 [2]. Patients with pre-existing stage 2 hypertension (above 160/100 mmHg) were excluded from that trial, and the FDA label recommends against initiating Jatenzo in patients with uncontrolled hypertension [1].

Hematocrit should be checked at 3 months, then at 6 months, then annually. The Endocrine Society guideline states: "If hematocrit rises above 54%, stop therapy until it decreases to a safe level; evaluate the patient for hypoxia and sleep apnea" [8]. Hawaii's outdoor population has a slightly elevated baseline prevalence of sleep-disordered breathing among shift workers in hospitality and agriculture, making this monitoring point clinically relevant.

Patients should take each capsule with a meal containing at least 10 grams of fat. Absorption drops significantly with a completely fat-free meal because lymphatic uptake requires dietary lipid to form chylomicrons. A small study published in Therapeutic Advances in Urology (2021) confirmed that coadministration with a standard breakfast (approximately 15 grams of fat) produced testosterone C-avg values approximately 32% higher than administration with a fat-free meal [15].

Pharmacy Options and Shipping to Hawaiian Islands

Hawaii residents have three main pharmacy channels for Jatenzo:

Retail chain pharmacies. CVS, Longs Drugs (a CVS subsidiary that is the dominant retail pharmacy chain across Hawaii), Walgreens, and Costco Pharmacy all stock or can order Jatenzo 237 mg capsules. Stock availability varies by location; Oahu locations maintain more consistent inventory than neighbor island stores. Patients should call ahead to confirm stock before submitting the prescription.

Mail-order pharmacies. Express Scripts, CVS Caremark, and OptumRx all ship Jatenzo to Hawaii addresses. Standard mail-order for a 90-day supply takes 7 to 10 business days to Oahu and 8 to 12 business days to neighbor islands via USPS Priority Mail or UPS Ground. Overnight shipping is available for an additional fee.

503A compounding pharmacies with Hawaii shipping licenses. Several nationally accredited 503A pharmacies that compound oral testosterone undecanoate hold Hawaii pharmacy permits and ship via FedEx overnight to all major islands. Overnight delivery to Maui, Kauai, Lanai, and Molokai is generally reliable except during periods of air-cargo disruption caused by severe weather.

The Hawaii Board of Pharmacy maintains a public database of pharmacies licensed to operate in the state, accessible through the Hawaii Department of Commerce and Consumer Affairs professional licensing portal [16].

Blood Pressure Management During Jatenzo Therapy in Hawaii

The boxed warning on Jatenzo is one of two black box warnings among FDA-approved testosterone products specifically tied to hypertension risk. Prescribers in Hawaii should document baseline blood pressure before initiating therapy, reassess at 28 days, and maintain a blood pressure monitoring plan throughout treatment [1].

For patients whose blood pressure rises above 130/80 mmHg during therapy, clinical options include dietary sodium reduction, increased aerobic activity, antihypertensive pharmacotherapy, or Jatenzo dose reduction. If blood pressure reaches or exceeds 160/100 mmHg and does not respond to non-pharmacologic intervention within 30 days, the American Heart Association 2017 guideline recommends antihypertensive drug therapy [17]. Prescribers managing Jatenzo patients with rising blood pressure should coordinate with the patient's primary care provider or cardiologist rather than managing both conditions in isolation.

Hawaii's high rate of Asian and Native Hawaiian/Pacific Islander patients warrants attention: these populations carry a higher age-standardized prevalence of hypertension compared with non-Hispanic white populations, according to CDC surveillance data [18]. Baseline blood pressure screening before Jatenzo initiation is not optional in this context; it is a clinical and legal necessity given the FDA label language.

Cost, Insurance, and Financial Assistance in Hawaii

Jatenzo's cash-pay retail price sits between $550 and $750 per 30-day supply at Hawaii retail pharmacies, consistent with national pricing data from GoodRx and the Tolmar patient support program [1]. HMSA commercial plans that cover testosterone therapy generally place Jatenzo on Tier 3 or Tier 4 of the formulary, resulting in co-pays of $60 to $150 per month after deductible for covered patients [10].

Hawaii Medicaid (Med-QUEST) does not cover Jatenzo for male hypogonadism as of the date of this article's review. Testosterone cypionate injection (generic) remains the preferred Med-QUEST-covered formulation for hypogonadism in Hawaii, available at approximately $40 per 10 mL vial [10].

For commercially insured patients facing step therapy requirements, completing a 60-day trial of testosterone cypionate injections and documenting either inadequate response (testosterone C-avg persistently below 400 ng/dL on optimized dosing) or intolerance (injection-site reactions, mood fluctuation tied to peak-trough cycling) provides a clinical basis for escalating to Jatenzo and submitting a PA appeal [8][1]. The Endocrine Society guideline supports individualized formulation selection when a standard formulation fails to achieve therapeutic goals [8].